Ravuconazole

Source: Wikipedia, the free encyclopedia.
Ravuconazole
Clinical data
ATC code
  • None
Identifiers
  • 4-[2-[(2R,3R)-3-(2,4-Difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile
JSmol)
  • C[C@@H](c1nc(-c2ccc(C#N)cc2)cs1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F
  • InChI=1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-7-6-17(23)8-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1 ☒N
  • Key:OPAHEYNNJWPQPX-RCDICMHDSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Ravuconazole (codenamed BMS-207147 and ER-30346) is a potent

Zygomycetes.[3][4]

See also

References

  1. ^ "Ravuconazole". AdisInsight. Springer Nature Switzerland AG. Retrieved 12 November 2017.
  2. ^ Pasqualotto AC, Denning DW. "Ravuconazole". The Aspergillus Website. Retrieved 18 February 2010.
  3. PMID 20112166
    .
  4. PMID 11897586
    .

External links
drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Ravuconazole&oldid=1180527932"